← FDA DRUG APPROVALS

FDA NDA · NDA018738

SULCONAZOLE NITRATE

Sponsor: JOURNEY

APPLICATION
NDA018738
TYPE
NDA
ORIGINAL APPROVAL
1985-08-30
LATEST ACTION
2014-05-19
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

EXELDERM · ReferenceDiscontinued
SULCONAZOLE NITRATE 1% · SOLUTION · TOPICAL

Approval history

2014-05-19Manufacturing (CMC) · Supplement 14 · standardAP
2009-07-08Manufacturing (CMC) · Supplement 9 · standardLabelAP
2003-05-30Labeling · Supplement 7 · standardLabelAP
2001-10-19Manufacturing (CMC) · Supplement 8 · standardAP
1993-09-22Manufacturing (CMC) · Supplement 6 · standardAP
1991-03-08Manufacturing (CMC) · Supplement 5 · standardAP
1991-02-14Manufacturing (CMC) · Supplement 4 · standardAP
1990-08-20Labeling · Supplement 2AP
1990-07-20Manufacturing (CMC) · Supplement 3 · standardAP
1986-12-18Manufacturing (CMC) · Supplement 1 · standardAP
1985-08-30Type 1 - New Molecular Entity · Original · standardReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →